Tag Archives: opioid

[ad_1] In addition, they must have the medicine in hand. Many pharmacies that do not supply naloxone have said they do not have available storage space, given all the most popular medications …

[ad_1] (Reuters Health) – Despite state laws expanding access to the opioid-overdose antidote naloxone without a prescription, two U.S. studies suggest many pharmacies don’t stock the drug or make it easily available …

[ad_1] While there have been some positive trends in the epidemic at the national level, New England, New Jersey's death rate has been rising steadily. Nearly 2,700 overdoses have been confirmed in …

[ad_1] EUGENE, Ore. (AP) — The Oregon Health Authority has released new guidelines for prescribing opioids to patients with short-term acute pain. The Register-Guard reports that it’s part of a larger strategy …

[ad_1] Updated 14 hours ago PHILADELPHIA – The first time Nicki Saccomanno used fentanyl, she overdosed. That was in 2016, and the 38-year-old Kensington woman did not know that the drugs she …

[ad_1] RED BATON – Critics across the country are wondering why the drug Dsuvia is needed. It's a new opioid and painkiller recently approved by the FDA, but many do not agree …

[ad_1] PHILADELPHIA (AP) – The first time Nicki Saccomanno used fentanyl, she overdosed. It was 2016, and the 38-year-old from Kensington had not known that the drugs had been cut with the …

[ad_1] The Food and Drug Administration approved a controversial new opioid formulation this month, even as critics warned that it would likely be abused.  The drug, called Dsuvia, is a synthetic opioid …

[ad_1] Written by Alia Paavola | November 09, 2018 | <a href = "http://www.beckershospitalreview.com/supply-chain/an-opioid-10-times-stronger-than-fentanyl-a-reformulated-asthma-inhaler-more-5-latest-fda-approvals .html? tmpl = component & print = 1 & layout = default "data-tracking =" print "title =" Print …

[ad_1] This image is provided by AcelRx Pharmaceuticals shows the dispenser and a tablet for the company Dsuvia. On Friday, Nov. 2. 2018, U.S. regulators announced the approval of the fast-acting, super-potent …